204 related articles for article (PubMed ID: 31665623)
1. HIV-1 Vif Triggers Cell Cycle Arrest by Degrading Cellular PPP2R5 Phospho-regulators.
Salamango DJ; Ikeda T; Moghadasi SA; Wang J; McCann JL; Serebrenik AA; Ebrahimi D; Jarvis MC; Brown WL; Harris RS
Cell Rep; 2019 Oct; 29(5):1057-1065.e4. PubMed ID: 31665623
[TBL] [Abstract][Full Text] [Related]
2. Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling.
Salamango DJ; McCann JL; Demir Ö; Becker JT; Wang J; Lingappa JR; Temiz NA; Brown WL; Amaro RE; Harris RS
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847850
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of PP2A is an independent and conserved function of HIV-1 Vif and causes cell cycle arrest.
Marelli S; Williamson JC; Protasio AV; Naamati A; Greenwood EJ; Deane JE; Lehner PJ; Matheson NJ
Elife; 2020 Apr; 9():. PubMed ID: 32292164
[TBL] [Abstract][Full Text] [Related]
4. Critical role of PP2A-B56 family protein degradation in HIV-1 Vif mediated G2 cell cycle arrest.
Nagata K; Shindo K; Matsui Y; Shirakawa K; Takaori-Kondo A
Biochem Biophys Res Commun; 2020 Jun; 527(1):257-263. PubMed ID: 32446377
[TBL] [Abstract][Full Text] [Related]
5. Demystifying Cell Cycle Arrest by HIV-1 Vif.
Salamango DJ; Harris RS
Trends Microbiol; 2021 May; 29(5):381-384. PubMed ID: 33478820
[TBL] [Abstract][Full Text] [Related]
6. Evolutionary Conservation of PP2A Antagonism and G2/M Cell Cycle Arrest in Maedi-Visna Virus Vif.
Luperchio AM; Jónsson SR; Salamango DJ
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016323
[TBL] [Abstract][Full Text] [Related]
7. Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif.
Zhao K; Du J; Rui Y; Zheng W; Kang J; Hou J; Wang K; Zhang W; Simon VA; Yu XF
Cell Cycle; 2015; 14(6):838-47. PubMed ID: 25590520
[TBL] [Abstract][Full Text] [Related]
8. Vif-CBFβ interaction is essential for Vif-induced cell cycle arrest.
Du J; Rui Y; Zheng W; Li P; Kang J; Zhao K; Sun T; Yu XF
Biochem Biophys Res Commun; 2019 Apr; 511(4):910-915. PubMed ID: 30851937
[TBL] [Abstract][Full Text] [Related]
9. Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest.
Salamango DJ; Harris RS
Front Microbiol; 2020; 11():622012. PubMed ID: 33510734
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into PPP2R5A degradation by HIV-1 Vif.
Hu Y; Delviks-Frankenberry KA; Wu C; Arizaga F; Pathak VK; Xiong Y
Nat Struct Mol Biol; 2024 May; ():. PubMed ID: 38789685
[TBL] [Abstract][Full Text] [Related]
11. Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.
Baig TT; Feng Y; Chelico L
J Virol; 2014 Dec; 88(24):14380-95. PubMed ID: 25275135
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1.
Ikeda T; Shimizu R; Nasser H; Carpenter MA; Cheng AZ; Brown WL; Sauter D; Harris RS
mBio; 2023 Aug; 14(4):e0078223. PubMed ID: 37555667
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific.
Evans EL; Becker JT; Fricke SL; Patel K; Sherer NM
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321323
[TBL] [Abstract][Full Text] [Related]
14. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
[TBL] [Abstract][Full Text] [Related]
15. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
16. Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.
Matsui Y; Shindo K; Nagata K; Yoshinaga N; Shirakawa K; Kobayashi M; Takaori-Kondo A
J Biol Chem; 2016 Nov; 291(48):24892-24899. PubMed ID: 27758855
[TBL] [Abstract][Full Text] [Related]
17. Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants.
Greenwood EJ; Matheson NJ; Wals K; van den Boomen DJ; Antrobus R; Williamson JC; Lehner PJ
Elife; 2016 Sep; 5():. PubMed ID: 27690223
[TBL] [Abstract][Full Text] [Related]
18. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
Zhang W; Du J; Evans SL; Yu Y; Yu XF
Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
[TBL] [Abstract][Full Text] [Related]
19. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.
Han X; Liang W; Hua D; Zhou X; Du J; Evans SL; Gao Q; Wang H; Viqueira R; Wei W; Zhang W; Yu XF
J Virol; 2014 Mar; 88(6):3320-8. PubMed ID: 24390335
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.
Izumi T; Io K; Matsui M; Shirakawa K; Shinohara M; Nagai Y; Kawahara M; Kobayashi M; Kondoh H; Misawa N; Koyanagi Y; Uchiyama T; Takaori-Kondo A
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20798-803. PubMed ID: 21071676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]